Harvard Bioscience Q3 Adjusted EPS $0.01 Misses $0.04 Estimate, Sales $25.36M Miss $28.02M Estimate
Author: Benzinga Newsdesk | November 07, 2023 08:08am
Harvard Bioscience (NASDAQ:
HBIO) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.04 by 75 percent. This is a 200 percent increase over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $25.36 million which missed the analyst consensus estimate of $28.02 million by 9.48 percent. This is a 5.79 percent decrease over sales of $26.92 million the same period last year.
Posted In: HBIO